Urine biomarkers of kidney injury among adolescents in Nicaragua, a region affected by an epidemic of chronic kidney disease of unknown aetiology

Nephrology Dialysis Transplantation

Volumn 31, Issue 3, 2016, Pages 424-432

  Ramírez Rubio, Oriana ^a,b   Amador, Juan José ^b   Kaufman, James S ^c   Weiner, Daniel E ^d   Parikh, Chirag R ^e,f   Khan, Usman ^e,f   Mcclean, Michael D ^b   Laws, Rebecca L ^b   López Pilarte, Damaris ^b   Friedman, David J ^g   Kupferman, Joseph ^g   Brooks, Daniel R ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b BOSTON UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adolescents; chronic kidney disease; Mesoamerican Nephropathy; Nicaragua; urine biomarkers

Indexed keywords

ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER; INTERLEUKIN 18; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MICROALBUMINURIA; NICARAGUA; PRIORITY JOURNAL; URINALYSIS; URINE DIPSTICK; URINE LEVEL; URINE STRIP READER; CLINICAL TRIAL; INCIDENCE; MULTICENTER STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; URINE;

ADOLESCENT; BIOMARKERS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; NICARAGUA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84960192906     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv292     Document Type: Article

References (44)

1. Ramirez-Rubio O, McClean MD, Amador JJ, et al. An epidemic of chronic kidney disease in Central America: an overview. J Epidemiol Community Health 2013; 67: 1-3
2. Weiner DE, McClean MD, Kaufman JS, et al. The Central American epidemic of CKD. Clin J Am Soc Nephrol 2013; 8: 504-511
3. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 2014; 63: 506-520
4. Yaqub F. Kidney disease in farming communities remains amystery. Lancet 2014; 383: 1794-1795
5. Torres C, Aragon A, Gonzalez M, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis 2010; 55: 485-496
6. Peraza S, Wesseling C, Aragon A, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 2012; 59: 531-540
7. Pan American Health Organization (PAHO). Chronic Kidney Disease in Agricultural Communities in Central America. CD52/8 Directing Council, 2013. http://iris.paho.org/xmlui/handle/123456789/4401 (June 2015, date last accesed
8. Raines N, Gonzalez M, Wyatt C, et al. Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. MEDICC Rev 2014; 16: 16-22
9. Orantes CM, Herrera R, AlmaguerM, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev 2011; 13: 14-22
10. Laux TS, Bert PJ, Barreto Ruiz GM, et al. Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-altitude, coffeegrowing village. J Nephrol 2012; 25: 533-540
11. O'Donnell JK, TobeyM, Weiner DE, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant 2011; 26: 2798-2805
12. Sanoff SL, Callejas L, Alonso CD, et al. Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail 2010; 32: 766-777
13. Gracia-Trabanino R, Dominguez J, Jansa JM, et al. [Proteinuria and chronic renal failure in the coast of El Salvador: detection with low cost methods and associated factors]. Nefrologia 2005; 25: 31-38
14. Wesseling C, Crowe J, Hogstedt C, et al. Resolving the enigma of the mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis 2014; 63: 396-404
15. Ordunez P, Saenz C, Martinez R, et al. The epidemic of chronic kidney disease in Central America. Lancet Global Health 2014; 2: e440-e441
16. Brooks DR, Ramirez-Rubio O, Amador JJ. CKD in Central America: a hot issue. Am J Kidney Dis 2012; 59: 481-484
17. Soderland P, Lovekar S, Weiner DE, et al. Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 2010; 17: 254-264
18. Ramirez-Rubio O, Brooks DR, Amador JJ, et al. Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health 2013; 13: 350
19. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 2014; 86: 294-302
20. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-S266
21. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinaseassociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-1024
22. Skalova S, Chladek J. Urinary N-acetyl-beta-D-glucosaminidase activity in healthy children. Nephrology (Carlton) 2004; 9: 19-21
23. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16: 3046-3052
24. Ministry of Health, Nicaragua. [Norma y protocolo para el abordaje de la enfermedad renal crónica]. 2010. http://www.minsa.gob.ni/index.php/repository/Descargas-MINSA/Direcci%C3%B3n-General-de-Regulaci%C3%B3n-Sanitaria/Normas-Protocolos-y-Manuales/Normas-2009/Normativa-016-Norma-y-protocolo-para-el-abordaje-de-la-enfermedadrenal-cr%C3%B3nica/(May 2015, date last accessed
25. Hornung RWR, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990; 5: 46-51
26. Wijkstrom J, Leiva R, Elinder CG, et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 2013; 62: 908-918
27. Lopez-Marin L, Chavez Y, Garcia XA, et al. Histopathology of chronic kidney disease of unknown etiology in Salvadoran agricultural communities. MEDICC Rev 2014; 16: 49-54
28. Laws RL, Brooks DR, Amador JJ, Weiner DE, et al. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health 2014. doi: 10.1179/2049396714Y.0000000102
29. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 2011; 23: 194-200
30. Smith ER, Lee D, Cai MM, et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with nonproteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant 2013; 28: 1569-1579
31. McCleanM, Amador J, Laws Ret al. Biological SamplingReport: Investigating Biomarkers of Kidney Injury and ChronicKidney DiseaseAmongWorkers in Western Nicaragua. Boston University School of Public Health, 2012. http://www.cao-ombudsman.org/cases/document-links/documents/Biological- Sampling-Report-April-2012.pdf (May 2015, date last accessed
32. Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinaseassociated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 2008; 23: 403-412
33. Cangemi G, Storti S, Cantinotti M, et al. Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform. Clin Chem Lab Med 2013; 51: 1101-1105
34. Rybi-Szuminska A, Wasilewska A, LitwinMet al. Paediatric normative data for urine NGAL/creatinine ratio. Acta Paediatr 2013; 102: e269-e272
35. Stefanovic V, Cukuranovic R, Djordjevic V, et al. Tubular marker excretion in children from families with Balkan nephropathy. Pediatr Nephrol 2009; 24: 2155-2166
36. Trachtenberg F, Barregard L. The effect of age, sex, and race on urinary markers of kidney damage in children. Am J Kidney Dis 2007; 50: 938-945
37. Kaneko K, Chiba M, HashizumeMet al. Renal tubular dysfunction in children living in the Aral Sea Region. Arch Dis Child 2003; 88: 966-968
38. Skinner AM, Addison GM, Price DA. Changes in the urinary excretion of creatinine, albumin and N-acetyl-beta-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 1996; 155: 596-602
39. Pennemans V, Rigo JM, Faes C, et al. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue. Clin Chem Lab Med 2013; 51: 1795-1802
40. Du Y, Zappitelli M, Mian A, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center. Pediatr Nephrol 2011; 26: 267-274
41. Belcher JM, Edelstein CL, Parikh CR. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis 2011; 57: 930-940
42. Coca SG, Garg AX, Thiessen-Philbrook H, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 2014; 25: 1063-1071
43. Koyner JL, Garg AX, Coca SG, et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 2012; 23: 905-914
44. Nauta FL, Bakker SJ, Lambers HeerspinkH, et al. Effect of frozen storage on urinary concentration of kidney damage markers. Am J Kidney Dis 2012; 59: 586-589